Author

C. Sereduk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1 Research Focus:spatial domain detection· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Hawkins-Daarud· 1 shared A. N. Karnezis· 1 shared A. R. A. Anderson· 1 shared A. Sekulic· 1 shared B. C. Vanderhyden· 1 shared B. E. Weissman· 1 shared B. R. Bendok· 1 shared C. Krishna· 1 shared

Activity by Year

2017-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hawkins-Daarud

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mapping multiregional imaging-localized biopsies to MRI habitats reveals biologically significant glioma tissue states and associated patterns of cohabitating cellular subpopulations

L. Curtin, K. M. Bond, P. R. Jackson, A. Hawkins-Daarud, S. Velez, N. Shakir, J. C. Urcuyo, G. De Leon, K. W. Singleton, J. M. Langworthy, K. Clark-Swanson, Y. Lassiter-Morris, L. Paulson, C. Sereduk, C. Krishna, , K. R. Swanson

The paper maps MRI-localized glioma biopsies to MRI habitats, identifying transcriptional tissue states and their association with cellular subpopulations and MRI features.

bioRxiv · Mar 23, 2022 · PreprintCancer Biology

Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition

J. D. Lang, W. P. D. Hendricks, H. Yin, J. Kiefer, P. Ramos, R. Sharma, P. Pirrotte, E. A. Raupach, C. Sereduk, N. Tang, W. S. Liang, M. Washington, S. J. Facista, V. L. Zismann, E. M. Cousins, , J. M. Trent

This paper identifies ponatinib as a potent treatment for SCCOHT by inhibiting multiple kinases in preclinical models.

bioRxiv · Jul 6, 2017Cancer Biology